Heyman M R, Sweet T
Department of Medicine, University of Maryland Cancer Center, Baltimore.
South Med J. 1990 Dec;83(12):1471-4. doi: 10.1097/00007611-199012000-00025.
Plasma infusion and/or plasma exchange has become standard therapy in the treatment of thrombotic thrombocytopenic purpura (TTP). The management of patients in whom such primary therapy fails is difficult and uncertain. We have described a patient who obtained a sustained remission with the use of high-dose IV gamma globulin after an initial response to aggressive plasma exchange was followed by prompt relapse. Our case and others suggest that high-dose IV IgG may induce remission in patients with TTP who do not respond to standard plasma infusion and/or exchange.
血浆输注和/或血浆置换已成为血栓性血小板减少性紫癜(TTP)治疗的标准疗法。对于这类初始治疗失败的患者,管理起来困难且具有不确定性。我们描述了一名患者,其在积极的血浆置换初始有反应后迅速复发,随后使用大剂量静脉注射丙种球蛋白获得了持续缓解。我们的病例及其他病例表明,大剂量静脉注射免疫球蛋白可能使对标准血浆输注和/或置换无反应的TTP患者实现缓解。